ZA200202655B - Hexahydrofuro[2,3-b]furan-3-yl-N-{3-[(1,3-benzodioxol -5-ylsulfonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor. - Google Patents

Hexahydrofuro[2,3-b]furan-3-yl-N-{3-[(1,3-benzodioxol -5-ylsulfonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor.

Info

Publication number
ZA200202655B
ZA200202655B ZA200202655A ZA200202655A ZA200202655B ZA 200202655 B ZA200202655 B ZA 200202655B ZA 200202655 A ZA200202655 A ZA 200202655A ZA 200202655 A ZA200202655 A ZA 200202655A ZA 200202655 B ZA200202655 B ZA 200202655B
Authority
ZA
South Africa
Prior art keywords
hexahydrofuro
ylsulfonyl
benzodioxol
furan
carbamate
Prior art date
Application number
ZA200202655A
Other languages
English (en)
Inventor
Piet Tom Bert Paul Wigerinck
Guangyang Wang
Michael Eissenstat
John W Erickson
Original Assignee
Tibotec Pharm Ltd
Nat Inst Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd, Nat Inst Health filed Critical Tibotec Pharm Ltd
Publication of ZA200202655B publication Critical patent/ZA200202655B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA200202655A 1999-10-06 2002-04-04 Hexahydrofuro[2,3-b]furan-3-yl-N-{3-[(1,3-benzodioxol -5-ylsulfonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor. ZA200202655B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15785099P 1999-10-06 1999-10-06

Publications (1)

Publication Number Publication Date
ZA200202655B true ZA200202655B (en) 2003-09-23

Family

ID=22565540

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200202655A ZA200202655B (en) 1999-10-06 2002-04-04 Hexahydrofuro[2,3-b]furan-3-yl-N-{3-[(1,3-benzodioxol -5-ylsulfonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor.

Country Status (26)

Country Link
US (2) US6649651B1 (xx)
EP (1) EP1222192B8 (xx)
JP (1) JP4951179B2 (xx)
KR (1) KR100792391B1 (xx)
CN (1) CN1191256C (xx)
AP (1) AP1459A (xx)
AT (1) ATE398623T1 (xx)
AU (1) AU781656B2 (xx)
BR (1) BR0014602A (xx)
CA (1) CA2386850C (xx)
CZ (1) CZ300031B6 (xx)
DE (1) DE60039244D1 (xx)
DK (1) DK1222192T3 (xx)
ES (1) ES2307533T3 (xx)
HK (1) HK1054746A1 (xx)
HU (1) HU228938B1 (xx)
IL (2) IL149005A0 (xx)
MX (1) MXPA02003607A (xx)
NO (1) NO327996B1 (xx)
NZ (1) NZ518580A (xx)
OA (1) OA12053A (xx)
PL (1) PL204924B1 (xx)
RU (1) RU2247123C2 (xx)
SK (1) SK287153B6 (xx)
WO (1) WO2001025240A1 (xx)
ZA (1) ZA200202655B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ518580A (en) * 1999-10-06 2004-01-30 Us Gov Health & Human Serv Hexahydrofuro[2,3-B]furan-3-YL-N- {3-[1,3-benzodioxol-5-ylsulfonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor
CN100491360C (zh) * 2001-04-09 2009-05-27 泰博特克药品有限公司 广谱2-(取代的-氨基)-苯并唑磺酰胺hiv蛋白酶抑制剂
DE60234952D1 (de) * 2001-09-10 2010-02-11 Tibotec Pharm Ltd VERFAHREN ZUR HERSTELLUNG VON HEXAHYDROFUROc2,3-BÜFURAN-3-OL
US7285566B2 (en) * 2002-01-07 2007-10-23 Erickson John W Resistance-repellent retroviral protease inhibitors
EP1483254A4 (en) * 2002-01-07 2005-06-08 Sequoia Pharmaceuticals INHIBITORS OF ANTI-RESISTANCE RETROVIRAL PROTEASE
US7157489B2 (en) * 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
IL165043A0 (en) 2002-05-17 2005-12-18 Tibotec Pharm Ltd broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
KR101327772B1 (ko) * 2002-08-02 2013-11-11 얀센 알 앤드 디 아일랜드 광범위 2-아미노-벤조티아졸 설폰아미드 ｈｉｖ 프로테아제 저해제
EP1589018A4 (en) 2002-12-27 2007-03-14 Sumitomo Chemical Co PROCESS FOR PRODUCING A DERIVATIVE OF HEXAHYDROFURANOL, INTERMEDIATE THEREOF AND PROCESS FOR PRODUCING THE SAME
MXPA06010365A (es) * 2004-03-11 2007-05-04 Sequoia Pharmaceuticals Inc Inhibidores de proteasa retrovirales repelentes a la resistencia.
TWI383975B (zh) 2004-03-31 2013-02-01 Tibotec Pharm Ltd 製備（３Ｒ，３ａＳ，６ａＲ）六氫-呋喃并〔２，３-ｂ〕呋喃-３-醇之方法
KR100698291B1 (ko) * 2004-12-29 2007-03-22 엘지전자 주식회사 조명계
JP5260965B2 (ja) 2005-02-25 2013-08-14 テイボテク・フアーマシユーチカルズ プロテアーゼ阻害剤前駆体合成
EP3696171A1 (en) 2006-07-07 2020-08-19 Gilead Sciences, Inc. Modulators of pharmacokinetic properties of therapeutics
US20090312318A1 (en) * 2006-07-24 2009-12-17 Desai Manoj C Therapeutic compounds and methods
CN102432621B (zh) 2006-11-09 2016-02-17 爱尔兰詹森科学公司 六氢呋喃并[2,3-b]呋喃-3-醇的制备方法
US9808527B2 (en) 2006-11-21 2017-11-07 Purdue Research Foundation Methods and compositions for treating HIV infections
ES2603617T3 (es) 2007-02-23 2017-02-28 Gilead Sciences, Inc. Moduladores de propiedades farmacocinéticas de la terapéutica
US7981929B2 (en) * 2007-03-16 2011-07-19 Sequoia Pharmaceuticals, Inc. Benzofuran derived HIV protease inhibitors
JP5393665B2 (ja) 2007-07-06 2014-01-22 ギリアード サイエンシーズ， インコーポレイテッド 治療剤の薬物動態特性の調整剤
EP2231628B1 (en) 2008-01-04 2015-10-28 Gilead Sciences, Inc. Inhibitors of cytochrome p450
US20110046199A1 (en) * 2008-01-17 2011-02-24 Purdue Research Foundation Small molecule inhibitors of hiv proteases
WO2010002994A1 (en) 2008-07-01 2010-01-07 Purdue Research Foundation Nonpeptide hiv-1 protease inhibitors
US8501961B2 (en) 2008-07-09 2013-08-06 Purdue Research Foundation HIV protease inhibitors and methods for using
NZ600156A (en) 2009-12-21 2015-01-30 Janssen R & D Ireland Degradable removable implant for the sustained release of an active compound
EP2643326B1 (en) 2010-11-23 2016-09-14 Mylan Laboratories, Limited Process for the preparation of (3R, 3aS, 6aR)-hexahydrofuro[2,3-b]furan-3-ol
ES2657227T3 (es) 2012-08-09 2018-03-02 Sumitomo Chemical Company, Limited Método para producir un derivado de hexahidrofurofuranol
CN103664976B (zh) * 2013-12-12 2015-11-04 惠州市莱佛士制药技术有限公司 一种顺式六氢呋喃并[2,3-b]呋喃-3-醇的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006030A1 (en) * 1993-08-24 1995-03-02 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
JP3657002B2 (ja) * 1992-08-25 2005-06-08 ジー．ディー．サール アンド カンパニー レトロウイルスプロテアーゼ阻害剤として有用なα−およびβ−アミノ酸ヒドロキシエチルアミノスルホンアミド
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5705500A (en) * 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
AU4828199A (en) 1998-06-23 2000-01-10 Board Of Trustees Of The University Of Illinois, The Multi-drug resistant retroviral protease inhibitors and associated methods
CA2336160C (en) * 1998-06-23 2015-02-17 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of compounds for treating hiv
GB9815567D0 (en) * 1998-07-18 1998-09-16 Glaxo Group Ltd Antiviral compound
NZ518580A (en) * 1999-10-06 2004-01-30 Us Gov Health & Human Serv Hexahydrofuro[2,3-B]furan-3-YL-N- {3-[1,3-benzodioxol-5-ylsulfonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor

Also Published As

Publication number Publication date
AU7663800A (en) 2001-05-10
AU781656B2 (en) 2005-06-02
KR100792391B1 (ko) 2008-01-08
PL354351A1 (en) 2004-01-12
IL149005A (en) 2006-12-31
CZ20021419A3 (cs) 2002-10-16
CA2386850A1 (en) 2001-04-12
CA2386850C (en) 2010-03-30
DK1222192T3 (da) 2008-10-20
OA12053A (en) 2006-05-02
AP2002002472A0 (en) 2002-06-30
HK1054746A1 (en) 2003-12-12
SK287153B6 (sk) 2010-01-07
RU2247123C2 (ru) 2005-02-27
US20050261364A1 (en) 2005-11-24
ES2307533T3 (es) 2008-12-01
US6649651B1 (en) 2003-11-18
CN1191256C (zh) 2005-03-02
IL149005A0 (en) 2002-11-10
EP1222192B1 (en) 2008-06-18
CN1407987A (zh) 2003-04-02
ATE398623T1 (de) 2008-07-15
SK5702002A3 (en) 2003-01-09
DE60039244D1 (de) 2008-07-31
NO20021598D0 (no) 2002-04-04
WO2001025240A1 (en) 2001-04-12
JP2003511383A (ja) 2003-03-25
HU228938B1 (hu) 2013-06-28
NO327996B1 (no) 2009-11-02
PL204924B1 (pl) 2010-02-26
MXPA02003607A (es) 2003-07-28
NZ518580A (en) 2004-01-30
NO20021598L (no) 2002-05-29
HUP0203130A2 (hu) 2003-01-28
HUP0203130A3 (en) 2005-01-28
EP1222192B8 (en) 2008-10-01
AP1459A (en) 2005-08-22
JP4951179B2 (ja) 2012-06-13
CZ300031B6 (cs) 2009-01-14
EP1222192A1 (en) 2002-07-17
KR20020067503A (ko) 2002-08-22
US7157495B2 (en) 2007-01-02
BR0014602A (pt) 2002-06-11

Similar Documents

Publication Publication Date Title
ZA200202655B (en) Hexahydrofuro[2,3-b]furan-3-yl-N-{3-[(1,3-benzodioxol -5-ylsulfonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor.
WO1999064047A8 (en) Novel antiviral compounds
ZA200107496B (en) Amine derivatives as protease inhitors.
ZA992447B (en) Quinoxalinones as serine protease inhibitors.
ZA200000075B (en) Enzymes mixture.
ZA200204283B (en) Novel antidiabetic agents.
ZA992344B (en) Game machine.
ZA991551B (en) 6,9-Disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines.
ZA200004319B (en) Game machine.
MXPA02005792A (es) 1-(aminofenil)-2-pirrolidonas como inhibidores de la integrina.
ZA991548B (en) 6,9-Disubstituted 2-[trans-(4-Aminocyclohexyl) Amino] Purines.
ZA200107096B (en) Woodworking jig.
ZA992445B (en) Benzoxazinones/benzothiazinones as serine protease inhibitors.
ZA200004373B (en) Game machine.
ZA985885B (en) External abrasive machine.
ZA99873B (en) Novel dihydroxyhexanoic acid derivatives.
ZA200110021B (en) Substituted imidazothiazoles as antidepressant agents.
MXPA03001783A (es) N-(3,5-dicloro-2-metoxifenil)-4-metoxi-3- piperazin-1 -il -bencenosulfonamida.
WO2001007408A3 (fr) Nouveau procede de preparation de composes benzoperhydroisoindole
ZA992214B (en) Oligomeric stabilizer mixture.
IL158033A0 (en) 3, 7-diazabicyclo [3.3.1] formulations as anti-arrhythmic compounds
HK1033656A1 (en) An interconnected block puzzle.
MXPA03006985A (es) Variantes de ap1 amino oxidasa.
ZA981168B (en) Compounds and processes for making herbicidal sulfonamides.
AP2005003385A0 (en) Grinding head.